JNBA Financial Advisors’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1
| Closed | – | – | 865 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 892 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 756 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 712 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 677 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 637 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 598 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 588 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 614 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 639 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 714 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 701 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 568 |
|
|
2018
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 738 |
|
|
2018
Q3 | – | Sell |
-1
| Closed | – | – | 732 |
|
|
2018
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 544 |
|
|
2018
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 511 |
|
|
2017
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 491 |
|
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 481 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 463 |
|
|
2017
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 503 |
|
|
2016
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1388 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | – | – | 1680 |
|
|
2016
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 554 |
|
|
2016
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 566 |
|
|
2015
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 550 |
|
|
2015
Q3 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 511 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 546 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 560 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 592 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 603 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 524 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 496 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 452 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 445 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 380 |
|